Page 6 - David Bartel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David bartel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Bartel Today - Breaking & Trending Today

Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) CFO Sells 977 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) CFO Jeffrey V. Poulton sold 977 shares of the business’s stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $194.59, for a total value of $190,114.43. Following the completion of the transaction, the chief financial officer now owns 11,706 shares […] ....

Thomas Tuschl , Phillip Zamore , Jeffreyv Poulton , David Bartel , Group Ltd , Sg Americas Securities , Fosun International Ltd , Canaccord Genuity Group , Jpmorgan Chase Co , Alnylam Pharmaceuticals Company Profile , Quarter For Alnylam Pharmaceuticals , Institutional Investors Weigh In On Alnylam Pharmaceuticals , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals Stock , News Ratings For Alnylam Pharmaceuticals Daily , Wealthfront Advisers , Get Rating , Genuity Group , Noble Laureate , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Insider Trading , Nsider Trades ,

Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) CMO Sells 1,839 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) CMO Pushkal Garg sold 1,839 shares of Alnylam Pharmaceuticals stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $194.59, for a total value of $357,851.01. Following the transaction, the chief marketing officer now owns 6,800 shares in the company, valued […] ....

Phillip Zamore , Thomas Tuschl , Pushkal Garg , David Bartel , Jpmorgan Chase Co , Quarter For Alnylam Pharmaceuticals , Securities Exchange Commission , Fosun International Ltd , Group Ltd , Ef Hutton Acquisition Co , Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Wealthfront Advisers , Sumitomo Mitsui Financial Group , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals Price Performance , Sg Americas Securities , Get Rating , Exchange Commission , Mitsui Financial Group , Noble Laureate , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Insider Trading , Nsider Trades ,

Handelsbanken Fonder AB Purchases 64,701 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Handelsbanken Fonder AB grew its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 50.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 192,294 shares of the biopharmaceutical company’s stock after acquiring an additional 64,701 shares during the quarter. Handelsbanken Fonder AB’s […] ....

Thomas Tuschl , Sanfordc Bernstein , David Bartel , Akshay Vaishnaw , Phillip Zamore , Mitsubishi Ufj , Insider Transactions At Alnylam Pharmaceuticals , Securities Exchange Commission , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals , Harvest Fund Management Co , Td Asset Management Inc , Ef Hutton Acquisition Co , Alnylam Pharmaceuticals Inc , Quarter For Alnylam Pharmaceuticals , Kokusai Asset Management Co , Westpac Banking Corp , Jpmorgan Chase Co , Exchange Commission , Alnylam Pharmaceuticals Stock , Handelsbanken Fonder , Get Rating , Management Inc , Asset Management , Banking Corp , Harvest Fund Management ,

Critical Comparison: Sernova (OTCMKTS:SEOVF) and Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) and Sernova (OTCMKTS:SEOVF – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares Alnylam Pharmaceuticals and Sernova’s net margins, return […] ....

City Of , United Kingdom , David Bartel , Paulr Schimmel , Thomas Tuschl , Phillip Zamore , Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Inc , Sernova Corp , Get Rating , Given Alnylam Pharmaceutical , Noble Laureate , Cell Pouch , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Stock Comparison , Stock Analysis ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) EVP Sells $735,000.00 in Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) EVP Indrani Lall Franchini sold 3,500 shares of the business’s stock in a transaction on Thursday, April 6th. The stock was sold at an average price of $210.00, for a total value of $735,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which […] ....

Thomas Tuschl , David Bartel , Phillip Zamore , Alnylam Pharmaceuticals Stock , Belpointe Asset Management , Guardian Wealth Advisors , Canaccord Genuity Group , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Securities Exchange Commission , Ci Investments Inc , Institutional Investors Weigh In On Alnylam Pharmaceuticals , Get Rating , Lall Franchini , Exchange Commission , Indrani Lall Franchini , Genuity Group , Asset Management , Wealth Advisors , Noble Laureate , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Insider Trading , Nsider Trades ,